Funding Rounds
TargED Biopharmaceuticals

TargED Biopharmaceuticals Series A (2022, $44M)

TargED Biopharmaceuticals

Biotechnology company developing innovative biological drugs to improve thrombosis treatment.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $44.23M

Raised Date: 2022-01-01

Investors